This will illuminate your mood.
A sudden new study found that some common drugs used to make people feel an improvement that may also be effective in fighting cancer.
“These medications have been widely used and safe to treat depression for decades, so reuse of cancer will be much easier than developing a completely new treatment,” said Dr. Lily Yang, a member of the ELYTHE Center at the UCLA Root Medicine Center.
Yang and her team found that selective serotonin absorption inhibitors, or SSRIS-medications such as Prozac and Silixa that millions of Americans take daily-can help T cells treat tumors with greater.
She said: “It turns out that SSRIS does not make our brains happier, but rather makes our cell T more-even while fighting tumors.”
In laboratory tests using both mouse models and human tumors – that extend skin, breast, prostate, colon and bladder – ssris shrinks with more than 50 % tumors.
Medicines have increased the killer-scold activity, which enhances their ability to locate and destroy cancer cells.
“SSRIS made deadly T cells happier in the repressive tumor environment otherwise by increasing their arrival to serotonin signals, and reactivating them to fight and kill cancer cells,” said Yang.
While serotonin is primarily known for organizing the mood, it also plays a decisive role in managing sleep, intestinal, appetite, strange and blood clotting.
Now, it is given due to the fight against this devastating disease.
The research, published in a cell magazine, has exciting effects for cancer treatment, because SSRIS is already accredited by the FDA, which paves the way for clinical trials.
She said: “Studies are estimated that the bench pipeline to bed for new cancer treatments cost an average of $ 1.5 billion.”
“When you compare this to the estimated cost of $ 300 million to reuse the drugs approved by the FDA (FDA), it is clear why this approach has a lot of capabilities.”
Even better?
When SSRIS was paired with current cancer immunotherapy, the results were more dramatic.
The treated mice see the tumors shrink dramatically, and in some cases, completely fade.
“The barriers of immune checkpoints are effective in less than 25 % of patients,” said James Elstane Brown, a high school student at the Yang Laboratory.
“If the drug is safe and widely available like SSRI can make these treatments more effective, it will be very influential.”
